Log In
BCIQ
Print this Print this
 

PQR309

Also known as: PQR-309

  Manage Alerts
Collapse Summary General Information
Company Piqur Therapeutics AG
DescriptionPhosphoinositide 3-kinase (PI3K) and mammalian target of rapamycin (mTOR; FRAP; RAFT1) inhibitor
Molecular Target Phosphoinositide 3-kinase (PI3K) ; Mammalian target of rapamycin (mTOR) (FRAP) (RAFT1)
Mechanism of ActionMammalian target of rapamycin (mTOR) kinase inhibitor; Phosphoinositide 3-kinase (PI3K) inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

02/17/2016

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today